Response from Piotr Mieszcazanski regarding Ceren Gunt's letter-RE: "Copeptin (CTproAVP) - A Biomarker of a Circulatory Impairment in Liver Transplant Recipients? A Prospective, Observational Study"

Transplant Proc. 2021 Dec;53(10):3103. doi: 10.1016/j.transproceed.2021.10.003. Epub 2021 Nov 22.

Author

Piotr Mieszczański¹

Affiliation

¹ 1st Department of Anaesthesiology and Intensive Care, Medical University of Warsaw, Warsaw, Poland. Electronic address: Piotr.mieszcazanski@gmail.com.

PMID: 34823898
DOI: 10.1016/j.transproceed.2021.10.003

No abstract available

Publication types

Observational Study
Letter

MeSH terms

Biomarkers
Glycopeptides
Humans
Liver Transplantation* / adverse effects
Prospective Studies

Substances

copeptins
Biomarkers
Glycopeptides